OBJECTIVE: To confirm that more than half of all idiopathic calcium oxalate (CaOx) stones grow on interstitial plaque, as CaOx stones can grow attached to interstitial apatite plaque but whether this is the usual mechanism of stone formation is uncertain. PATIENTS AND METHODS: In nine idiopathic CaOx stone formers (ICSF) undergoing percutaneous nephrolithotomy or ureteroscopy all accessible renal papillae were endoscopically imaged using a digital endoscope. All stones were removed intact, and recorded by the operating surgeon as being attached or unattached; for all attached stones the surgeon determined if the site of attachment was to plaque. This determination was further verified by reviewing the intraoperative video record, and only instances where plaque was reliably seen on video were used for analysis. Surgical observations were further validated by a combination of microcomputed tomographic analysis and papillary biopsy. The results were analysed statistically using fixed-sample testing and group sequential sampling. RESULTS: The nine patients had a total of 115 stones, primarily CaOx; 90 stones were attached. Of these, 81 were attached to plaque; surgeons could not visualize the site of attachment with sufficient clarity to judge in the other nine cases. Based on these data, the final point estimate for the number of stones attached to plaque was 0.754 (95% confidence interval 0.575-0.933; P = 0.013). CONCLUSIONS: In ICSF most stones grow attached to papillae, on plaque, so growth on plaque is the main mechanism for stone formation in this very common group of patients.
OBJECTIVE: To confirm that more than half of all idiopathic calcium oxalate (CaOx) stones grow on interstitial plaque, as CaOx stones can grow attached to interstitial apatite plaque but whether this is the usual mechanism of stone formation is uncertain. PATIENTS AND METHODS: In nine idiopathic CaOx stone formers (ICSF) undergoing percutaneous nephrolithotomy or ureteroscopy all accessible renal papillae were endoscopically imaged using a digital endoscope. All stones were removed intact, and recorded by the operating surgeon as being attached or unattached; for all attached stones the surgeon determined if the site of attachment was to plaque. This determination was further verified by reviewing the intraoperative video record, and only instances where plaque was reliably seen on video were used for analysis. Surgical observations were further validated by a combination of microcomputed tomographic analysis and papillary biopsy. The results were analysed statistically using fixed-sample testing and group sequential sampling. RESULTS: The nine patients had a total of 115 stones, primarily CaOx; 90 stones were attached. Of these, 81 were attached to plaque; surgeons could not visualize the site of attachment with sufficient clarity to judge in the other nine cases. Based on these data, the final point estimate for the number of stones attached to plaque was 0.754 (95% confidence interval 0.575-0.933; P = 0.013). CONCLUSIONS: In ICSF most stones grow attached to papillae, on plaque, so growth on plaque is the main mechanism for stone formation in this very common group of patients.
Authors: Ramsay L Kuo; James E Lingeman; Andrew P Evan; Ryan F Paterson; Joan H Parks; Sharon B Bledsoe; Larry C Munch; Fredric L Coe Journal: Kidney Int Date: 2003-12 Impact factor: 10.612
Authors: Charles Y C Pak; Beverley Adams-Huet; John R Poindexter; Margaret S Pearle; Roy D Peterson; Orson W Moe Journal: Kidney Int Date: 2004-11 Impact factor: 10.612
Authors: Brian R Matlaga; James C Williams; Samuel C Kim; Ramsay L Kuo; Andrew P Evan; Sharon B Bledsoe; Fredric L Coe; Elaine M Worcester; Larry C Munch; James E Lingeman Journal: J Urol Date: 2006-05 Impact factor: 7.450
Authors: Andrew P Evan; James E Lingeman; Fredric L Coe; Youzhi Shao; Joan H Parks; Sharon B Bledsoe; Carrie L Phillips; Stephen Bonsib; Elaine M Worcester; Andre J Sommer; Sam C Kim; William W Tinmouth; Marc Grynpas Journal: Kidney Int Date: 2005-02 Impact factor: 10.612
Authors: Andrew P Evan; James E Lingeman; Fredric L Coe; Joan H Parks; Sharon B Bledsoe; Youzhi Shao; Andre J Sommer; Ryan F Paterson; Ramsay L Kuo; Marc Grynpas Journal: J Clin Invest Date: 2003-03 Impact factor: 14.808
Authors: Andrew P Evan; Fredric L Coe; James E Lingeman; Youzhi Shao; Andre J Sommer; Sharon B Bledsoe; Jennifer C Anderson; Elaine M Worcester Journal: Anat Rec (Hoboken) Date: 2007-10 Impact factor: 2.064
Authors: Andrew P Evan; James E Lingeman; Elaine M Worcester; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Carrie L Philips; Fredric L Coe Journal: Kidney Int Date: 2010-04-28 Impact factor: 10.612
Authors: Amy E Krambeck; Naseem F Khan; Molly E Jackson; James E Lingeman; James A McAteer; James C Williams Journal: J Urol Date: 2010-08-21 Impact factor: 7.450
Authors: James C Williams; James E Lingeman; Fredric L Coe; Elaine M Worcester; Andrew P Evan Journal: Urolithiasis Date: 2014-08-06 Impact factor: 3.436
Authors: Xiangling Wang; Amy E Krambeck; James C Williams; Xiaojing Tang; Andrew D Rule; Fang Zhao; Eric Bergstralh; Zejfa Haskic; Samuel Edeh; David R Holmes; Loren P Herrera Hernandez; John C Lieske Journal: Clin J Am Soc Nephrol Date: 2014-08-04 Impact factor: 8.237